News Stories Pulled from Leading Newswires
Unique News Content Experiences for Any Website
NRx Pharmaceuticals Advances Toward FDA Approval for NRX-100 Under New Priority Voucher Program
NRx Pharmaceuticals leverages the FDA's new Commissioner’s National Priority Voucher program to fast-track the approval of NRX-100, a …
June 27, 2025
Source
Texas Governor Vetoes Measure to Ban Consumable THC Products
Governor Greg Abbott's veto preserves the market for THC products in Texas, impacting the cannabis industry and investors.
June 26, 2025
Source
Innovative Industrial Properties Inc. Emerges as a Leader in the Evolving Cannabis Industry
The cannabis industry's recent challenges have paved the way for disciplined companies like Innovative Industrial Properties Inc. to thrive, signaling …
June 25, 2025
Source
Missouri's New Cannabis Purchase Limits Spark Industry-Wide Attention
Missouri's revised guidelines on medical marijuana purchase limits are drawing scrutiny from advocates and industry leaders, highlighting the ongoing …
June 24, 2025
Source
NRx Pharmaceuticals Enhances Corporate Communications Strategy with IBN to Advance Mental Health Treatments
NRx Pharmaceuticals partners with IBN to boost awareness of its innovative therapies for suicidal depression and PTSD, highlighting the growing …
June 24, 2025
Source
Pennsylvania's Budget Debate Could Influence Cannabis Legalization
The ongoing budget negotiations in Pennsylvania may pave the way for marijuana legalization, impacting the cannabis industry and investors.
June 23, 2025
Source
High-Security Cannabis Facility Highlights Industry's Growth and Challenges
A high-security cannabis facility near a local sheriff's station underscores the industry's rapid expansion and the ongoing regulatory and security …
June 20, 2025
Source
Study Highlights Genetic Diversity Concerns in Legal Cannabis Industry
A recent study reveals the legal cannabis industry's focus on high-yield strains may be reducing the plant's genetic diversity, raising concerns among …
June 18, 2025
Source
Psyence Biomed's Chief of Global Impact to Speak at Psychedelic Science 2025
Mary-Elizabeth Gifford of Psyence Biomed will discuss business ethics at Psychedelic Science 2025, highlighting the company's role in advancing …
June 18, 2025
Source
Meta's Content Policy Shift Excludes Cannabis, Impacting Industry Visibility
Meta's decision to continue censoring cannabis-related content despite loosening rules on other controversial topics highlights ongoing challenges for …
June 17, 2025
Source
Carolindica Introduces Nano THC Pops: A Summer Game-Changer in Cannabis Consumption
Carolindica's launch of Nano THC Pops offers a novel, nostalgic way to enjoy hemp-derived Delta-9 THC, blending summer fun with fast-acting effects …
June 17, 2025
Source
Congress Shifts Focus to Hemp-Derived THC Restrictions Amid Cannabis Industry Growth
Lawmakers are moving to restrict hemp-derived THC products, a pivot from previous efforts to support the marijuana industry, impacting companies like …
June 16, 2025
Source
Perfect Union to Highlight Community Engagement at Morro Bay Seminar
Perfect Union, a leading cannabis retail brand, will discuss its community-focused approach at the Morro Bay Chamber of Commerce's Breakfast on the …
June 16, 2025
Source
Illicit Cannabis Sales in the UK Highlight Need for Policy Reform
The discovery of illicit cannabis sales via QR codes in the UK underscores the urgent need for drug policy reform and the potential benefits of a …
June 13, 2025
Source
Cybin Advances CYB003 into Phase 3 Development, Highlighting Progress in Psychedelic Therapeutics
Cybin Inc. progresses its lead psychedelic-based therapeutic, CYB003, into Phase 3 development, signaling significant strides in mental health …
June 13, 2025
Source
Federal Immigration Enforcement and the Cannabis Industry: Navigating Compliance Challenges
The article explores the challenges cannabis businesses face in complying with federal immigration laws amidst ongoing federal prohibition of …
June 12, 2025
Source
NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Amid National Shortage
NRx Pharmaceuticals has filed an Abbreviated New Drug Application for NRX-100, a preservative-free ketamine formulation, addressing the U.S. ketamine …
June 12, 2025
Source
Cybin CEO to Discuss Next-Gen Neuropsychiatric Treatments at H.C. Wainwright Conference
Cybin Inc. CEO Doug Drysdale will share insights on innovative psychedelic-based therapeutics at the H.C. Wainwright 6th Annual Neuro Perspectives …
June 12, 2025
Source
CannabisRadio.com Celebrates a Decade of Pioneering Cannabis and Psychedelic Media
CannabisRadio.com marks its 10th anniversary as a leading podcast network in the cannabis and psychedelic industries, highlighting its journey and …
June 12, 2025
Source
